Trial intelligence / Profile preview

Metformin and myocardial efficiency in chronic heart failure

2015-002767-42Phase 2Completed

Sponsor
Aarhus University Hospital
Start
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in chronic heart failure (CHF) comparing Metformin (Glucophage XR) with Placebo (2 arms). Primary endpoint: Myocardial efficiency. Started Apr 2016; status: completed.

02

Drugs

metformin
03

Conditions

chronic heart failure (CHF)

Beyond the preview

Go deeper on 2015-002767-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002767-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call